🔎 Trials Near Me

Home › Kanser sa Salivary Gland › Massachusetts

Pag-aaral pangklinika para sa Kanser sa Salivary Gland sa Massachusetts

6 pag-aaral para sa Kanser sa Salivary Gland ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

  • Boston Medical Center, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05408845

Integrated Cancer Repository for Cancer Research

  • Holyoke Medical Center, Holyoke
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT04620187

Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT05553782

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2025 · NCT06805617

Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.